Compound Summary
tetracaine
Compound Information
tetracaine
Compound Name: | tetracaine |
Compound CID: | 5411 |
Synonyms: | tetracaine 94-24-6 Amethocaine 2-(Dimethylamino)ethyl 4-(butylamino)benzoate Pontocaine More... |
Iupac Name: | 2-(dimethylamino)ethyl 4-(butylamino)benzoate |
InChI: | InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3 |
InChIKey: | GKCBAIGFKIBETG-UHFFFAOYSA-N |
Canonical Smiles: | CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C |
Isomeric Smiles: | CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C |
Molecular Weight: | 264.36 |
Molecular Formula: | C15H24N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
tetracaine
Molecular Weight: | 264.36 |
Molecular Formula: | C15H24N2O2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 9 |
Heavy Atom Count: | 19 |
Complexity: | 249 |
Synonyms
tetracaine
| tetracaine | tetracaine |
|---|---|
tetracaine |
94-24-6 |
Amethocaine |
2-(Dimethylamino)ethyl 4-(butylamino)benzoate |
Pontocaine |
Dicaine |
Laudocaine |
Metraspray |
Tetrakain |
Anetain |
Contralgin |
Meethobalm |
Mucaesthin |
Tetracaina |
Tetracainum |
Uromucaesthin |
Fissucain |
Intercain |
Medicaine |
Niphanoid |
Rexocaine |
Dicain |
Dikain |
Medihaler-Tetracaine |
2-(Dimethylamino)ethyl p-(butylamino)benzoate |
p-Butylaminobenzoyl-2-dimethylaminoethanol |
Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester |
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure |
4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester |
Dimethylaminoethyl p-butyl-aminobenzoate |
UNII-0619F35CGV |
CHEBI:9468 |
p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester |
MFCD00053787 |
CHEMBL698 |
BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER |
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove |
Tetracaine Base |
0619F35CGV |
Butylocaine |
Tetrakain Czech |
Tetracainum INN-Latin |
Tetracaina INN-Spanish |
p-(butylamino)benzoic acid beta-(dimethylamino)ethyl ester |
Amethocaine (TN) |
Tetracaine (USP/INN) |
NCGC00016049-02 |
CAS-136-47-0 |
EINECS 202-316-6 |
BRN 2216051 |
Landocaine |
Tetracaine USP:INN:BAN |
Amethocaine HCl |
2-Dimethylaminoethylester kyseliny p-butylaminobenzoove Czech |
Diaethylaminoaethanol ester der p-butylaminobenzoesaeure German |
TE4 |
Spectrum_001032 |
Pantocaine (Salt/Mix) |
100311-22-6 |
Prestwick0_000571 |
Prestwick1_000571 |
Prestwick2_000571 |
Prestwick3_000571 |
Spectrum2_001328 |
Spectrum3_000562 |
Spectrum4_000351 |
Spectrum5_001072 |
Lopac-T-7508 |
Epitope ID:174843 |
Lopac0_001211 |
SCHEMBL34714 |
BSPBio_000382 |
BSPBio_001944 |
KBioGR_000781 |
KBioSS_001512 |
4-14-00-01172 (Beilstein Handbook Reference) |
DivK1c_000607 |
SPBio_001455 |
SPBio_002601 |
BPBio1_000422 |
Tetracaine, >=98% (TLC) |
DTXSID1043883 |
KBio1_000607 |
KBio2_001512 |
KBio2_004080 |
KBio2_006648 |
KBio3_001444 |
NINDS_000607 |
BCPP000048 |
ACT04765 |
ALBB-025902 |
BCP04777 |
HY-A0079 |
ZINC1530811 |
BDBM50017659 |
SBB058194 |
STL483844 |
AKOS015889234 |
AC-3480 |
CCG-205285 |
DB09085 |
MCULE-8973928579 |
SDCCGSBI-0051178.P005 |
IDI1_000607 |
NCGC00016049-01 |
NCGC00016049-03 |
NCGC00016049-04 |
NCGC00016049-14 |
NCGC00162367-01 |
K715 |
ST099115 |
SY066710 |
BCP0726000001 |
SBI-0051178.P004 |
AB00053549 |
FT-0656378 |
T2789 |
Tetracaine, meets USP testing specifications |
.beta.-Dimethylaminoethyl p-butylaminobenzoate |
2-(Dimethylamino)ethyl4-(n-butylamino)benzoate |
C07526 |
D00551 |
2-(Dimethylamino)ethyl 4-(butylamino)benzoate # |
AB00053549-11 |
AB00053549_12 |
AB00053549_13 |
Q419608 |
Q-201805 |
BRD-K45071273-003-05-8 |
BRD-K45071273-003-15-7 |
Tetracaine, United States Pharmacopeia (USP) Reference Standard |
benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester ,hydrochloride |
BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER PANTOCAIN BASE |
Experimental Data
tetracaine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drosophila melanogaster | 20.000000000000000 | umol/L | 49.360000000000000 | 47.030000000000000 | -4.707000000000000 | NS | FEMALES | 33008901 | Inactive | ||||
| Drosophila melanogaster | 200.000000000000000 | umol/L | 45.820000000000000 | 47.270000000000000 | 3.177000000000000 | NS | MALES | 33008901 | Inactive |
Experimental Data Visualization
tetracaine
Statistics Data
tetracaine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Drosophila melanogaster | 3.177000000000000 | 1 | 2 |
Statistics Data Visualization
tetracaine
